SAN JOSE -- A Stanford University genetics professor has paid nearly $30 million in restitution after a judge determined that he misled investors in a now-dissolved biotechnology company he founded.

A prominent genetics professor at Stanford University in the US has paid $29 million to investors in Nuredis – a biotech that has now been wound up – after a California court found he ...

In the annals of corporate fraud, few stories resonate as powerfully as that of Theranos, the Silicon Valley biotech startup ...

Halo Biosciences ("Halo"), a clinical-stage biotechnology company developing extracellular matrix-targeted therapies, today ...

Marc Tessier-Lavigne, Ph.D., has resigned from his post as president of Stanford University after months ... as the Arch-launched neuroscience biotech laid out plans for three pivotal phase ...

Former Stanford University President Marc Tessier-Lavigne is leading a who's-who of biotech players — including Stanford Nobel laureate Carolyn Bertozzi, former Food and Drug Administration ...

Tessier-Lavigne, a neuroscientist and biotech entrepreneur ... 2023 Before he became Stanford’s president, Tessier-Lavigne served as president of Rockefeller University in New York, oversaw ...

Baker is a rising sophomore at Stanford University. At its daily student ... investigation found that as a neuroscientist and biotechnology executive, he had fostered an environment that led ...

Stanford University is celebrating 100 years of engineering, commemorating a century of innovation and showcasing the ...